Ampersand Biomedicines
Yue (Shawn) Shen is a scientist specializing in computational biology with extensive experience in data analysis and machine learning applied to drug discovery. Current position at Ampersand Biomedicines involves computational biology responsibilities since January 2024. Previously, at RVAC Medicines, Yue analyzed experimental data and developed deep learning models for RNA optimization. A graduate research assistant at the UT/ORNL Center for Molecular Biophysics, Yue led machine learning research projects and utilized computational biology methods. Early experience as a research assistant at the State Key Laboratory of Microbial Metabolism involved database management and Python scripting. Yue holds a PhD in Computational Biology and a Master's degree in Statistics from the University of Tennessee and a Bachelor's degree in Biotechnology from Shanghai Jiao Tong University.
This person is not in any offices
Ampersand Biomedicines
Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else. The company’s state-of-the-art computationally powered Address, Navigate, Design (AND)™ Platform continually learns the rules for identifying optimal localizer targets and refines its ability to design across the complex space of localizers and actuators. The result is increasingly sophisticated AND-Body™ therapeutics that are engineered across the physical constraints of molecules and the biological characteristics of the targets to effectively target the site of disease without affecting healthy tissue or cells. Ampersand Biomedicines was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering.